David A. Lewis
Auto-generated profile, based on publicly available information

David A. Lewis

Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA

Research Focus & Metrics

Academic Career Length

48Years (1979-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2005 in Nature Reviews Neuroscience
Verified
Journal Article
Closed access
DLDavid A. Lewis
David A. Lewis
THTakanori Hashimoto
Takanori Hashimoto
DVDavid W. Volk
David W. Volk

1 January 2000 in Archives of General Psychiatry
Verified
Journal Article
Closed access
LGLeisa A. Glantz
Leisa A. Glantz
DLDavid A. Lewis
David A. Lewis
The pathophysiological characteristics of schizophrenia appear to involve altered synaptic connectivity in the dorsolateral prefrontal cortex. Given the central role that layer 3 pyramidal neurons play in corticocortical and thalamocortical connectivity, we hypothesized that the excitatory inputs to these neurons are altered in subjects with schizophrenia. To test this hypothesis, we determined the density of dendritic spines, markers of excitatory inputs, on the basilar dendrites of Golgi-impregnated pyramidal neurons in the superficial and deep portions of layer 3 in the dorsolateral prefrontal cortex (area 46) and in layer 3 of the primary visual cortex (area 17) of 15 schizophrenic subjects, 15 normal control subjects, and 15 nonschizophrenic subjects with a psychiatric illness (referred to as psychiatric subjects). There was a significant effect of diagnosis on spine density only for deep layer 3 pyramidal neurons in area 46 (P = .006). In the schizophrenic subjects, spine density on these neurons was decreased by 23% and 16% compared with the normal control (P = .004) and psychiatric (P = .08) subjects, respectively. In contrast, spine density on neurons in superficial layer 3 in area 46 (P = .09) or in area 17 (P = .08) did not significantly differ across the 3 subject groups. Furthermore, spine density on deep layer 3 neurons in area 46 did not significantly (P = .81) differ between psychiatric subjects treated with antipsychotic agents and normal controls. This region- and disease-specific decrease in dendritic spine density on dorsolateral prefrontal cortex layer 3 pyramidal cells is consistent with the hypothesis that the number of cortical and/or thalamic excitatory inputs to these neurons is altered in subjects with schizophrenia.

26 September 2016 in Nature Neuroscience
Verified
Journal Article
Open access
PDF file
MFMenachem Fromer
Menachem Fromer
PRPanos Roussos
Panos Roussos
SSSolveig K Sieberts
Solveig K Sieberts
JJJessica S Johnson
Jessica S Johnson
DKDavid H Kavanagh
David H Kavanagh
PSPamela Sklar
Pamela Sklar
The CommonMind Consortium sequenced RNA from dorsolateral prefrontal cortex of subjects with schizophrenia (N = 258) and control subjects (N = 279), creating a resource of gene expression and its genetic regulation. Using this resource, they found that ∼20% of schizophrenia loci have variants that may contribute to altered gene expression and liability. Over 100 genetic loci harbor schizophrenia-associated variants, yet how these variants confer liability is uncertain. The CommonMind Consortium sequenced RNA from dorsolateral prefrontal cortex of people with schizophrenia (N = 258) and control subjects (N = 279), creating a resource of gene expression and its genetic regulation. Using this resource, ∼20% of schizophrenia loci have variants that could contribute to altered gene expression and liability. In five loci, only a single gene was involved: FURIN, TSNARE1, CNTN4, CLCN3 or SNAP91. Altering expression of FURIN, TSNARE1 or CNTN4 changed neurodevelopment in zebrafish; knockdown of FURIN in human neural progenitor cells yielded abnormal migration. Of 693 genes showing significant case-versus-control differential expression, their fold changes were ≤ 1.33, and an independent cohort yielded similar results. Gene co-expression implicates a network relevant for schizophrenia. Our findings show that schizophrenia is polygenic and highlight the utility of this resource for mechanistic interpretations of genetic liability for brain diseases.

1 January 2012 in Trends in Neurosciences
Verified
Journal Article
Closed access
DLDavid A. Lewis
David A. Lewis
ACAllison A. Curley
Allison A. Curley
JGJill R. Glausier
Jill R. Glausier
DVDavid W. Volk
David W. Volk

16 July 2003 in The Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
THTakanori Hashimoto
Takanori Hashimoto
DVDavid W. Volk
David W. Volk
SEStephen M. Eggan
Stephen M. Eggan
Karoly MirnicsKaroly Mirnics
Karoly Mirnics
JPJoseph N. Pierri
Joseph N. Pierri
DLDavid A. Lewis
David A. Lewis
Markers of inhibitory neurotransmission are altered in the prefrontal cortex (PFC) of subjects with schizophrenia, and several lines of evidence suggest that these alterations may be most prominent in the subset of GABA-containing neurons that express the calcium-binding protein, parvalbumin (PV). To test this hypothesis, we evaluated the expression of mRNAs for PV, another calcium-binding protein, calretinin (CR), and glutamic acid decarboxylase (GAD67) in postmortem brain specimens from 15 pairs of subjects with schizophrenia and matched control subjects using single- and dual-labelin situhybridization. Signal intensity for PV mRNA expression in PFC area 9 was significantly decreased in the subjects with schizophrenia, predominately in layers III and IV. Analysis at the cellular level revealed that this decrease was attributable principally to a reduction in PV mRNA expression per neuron rather than by a decreased density of PV mRNA-positive neurons. In contrast, the same measures of CR mRNA expression were not altered in schizophrenia. These findings were confirmed by findings from cDNA microarray studies using different probes. Across the subjects with schizophrenia, the decrease in neuronal PV mRNA expression was highly associated (r= 0.84) with the decrease in the density of neurons containing detectable levels of GAD67mRNA. Furthermore, simultaneous detection of PV and GAD67mRNAs revealed that in subjects with schizophrenia only 55% of PV mRNA-positive neurons had detectable levels of GAD67mRNA. Given the critical role that PV-containing GABA neurons appear to play in regulating the cognitive functions mediated by the PFC, the selective alterations in gene expression in these neurons may contribute to the cognitive deficits characteristic of schizophrenia.

6 February 2013 in Nature Reviews Neuroscience
Verified
Journal Article
Closed access
PDF file
JDJavier DeFelipe
Javier DeFelipe
PLPedro L. López-Cruz
Pedro L. López-Cruz
RBRuth Benavides-Piccione
Ruth Benavides-Piccione
CBConcha Bielza
Concha Bielza
PLPedro Larrañaga
Pedro Larrañaga
GAGiorgio Ascoli
Giorgio Ascoli